Search results for gsk3b

295 hits were found for gsk3b

# Family MCID Name MIFTS Score
1
P ALZ034 Alzheimer Disease 87 22.978
2
P CLR023 Colorectal Cancer 100 21.952
3
P BPL003 Bipolar Disorder 56 20.887
4
P PRS040 Prostate Cancer 95 18.759
5
P BRS047 Breast Cancer 98 17.775
6
P PNC035 Pancreatic Cancer 86 17.421
7
P MJR001 Major Depressive Disorder 68 17.377
8
P GST053 Gastric Cancer 83 17.111
9
P HPT023 Hepatocellular Carcinoma 96 16.355
10
P SCH015 Schizophrenia 74 16.260
11
END057 Endometrial Cancer 72 15.900
12
P PRK057 Parkinson Disease, Late-Onset 80 14.789
13
P DMN002 Dementia 66 14.108
14
P FML011 Familial Adenomatous Polyposis 71 13.706
15
c TYP009 Type 2 Diabetes Mellitus 92 12.838
16
P EPL164 Epilepsy 68 12.838
17
P NRB001 Neuroblastoma 66 12.612
18
P LVR013 Liver Disease 69 12.065
19
FRN006 Frontotemporal Dementia 68 11.648
20
P BND020 Bone Disease 59 10.624
21
P MDL005 Medulloblastoma 75 10.398
22
P DBT009 Diabetes Mellitus 67 10.398
23
c SVR003 Severe Congenital Neutropenia 59 9.851
24
P PLY014 Polycystic Kidney Disease 69 9.851
25
P ATT013 Attention Deficit-Hyperactivity Disorder 64 9.851
26
c SCH079 Schizophrenia 1 44 8.892
27
ANR009 Aneurysmal Bone Cysts 43 6.966
28
c ALZ045 Alzheimer Disease 9 45 6.966
29
c PRK085 Parkinson Disease 1, Autosomal Dominant 49 6.966
30
CRV020 Cervical Non-Keratinizing Squamous Cell Carcinoma 23 6.966
31
DSS008 Disease of Mental Health 74 6.966
32
OPH001 Ophthalmomyiasis 32 6.966
33
BRB002 Barbiturate Dependence 28 6.966
34
FLL015 Fallopian Tube Serous Adenocarcinoma 33 6.966
35
c MJR022 Major Affective Disorder 8 38 5.947
36
c MJR024 Major Affective Disorder 9 41 5.947
37
MNT002 Mental Depression 57 5.701
38
DPR016 Depression 65 5.388
39
MDD011 Mood Disorder 62 3.797
40
GLB002 Glioblastoma 67 3.382
41
P ADN016 Adenocarcinoma 63 2.889
42
MLD018 Mild Cognitive Impairment 48 2.821
43
ALC007 Alcohol Dependence 66 2.749
44
WLL004 Wallerian Degeneration 38 2.635
45
P LNG032 Lung Cancer 98 2.438
46
P LNG064 Lung Cancer Susceptibility 3 70 2.411
47
SQM006 Squamous Cell Carcinoma 60 2.378
48
P OVR042 Ovarian Cancer 88 2.301
49
c THY107 Thymoma, Familial 42 2.250
50
P THY023 Thymoma 64 2.250
51
ISC004 Ischemia 61 2.043
52
c ERL020 Early-Onset Schizophrenia 44 1.926
53
AGN018 Agenesis of Corpus Callosum, Cardiac, Ocular, and Genital Syndrome 57 1.926
54
P PLM036 Pulmonary Fibrosis 66 1.926
55
OST003 Osteonecrosis 61 1.926
56
P MLN008 Melanoma 76 1.926
57
c ATR087 Atrial Standstill 1 74 1.814
59
P RTT002 Rett Syndrome 79 1.797
60
APH002 Aphasia 56 1.797
61
DCT002 Ductal Carcinoma in Situ 58 1.797
62
PNC041 Pancreatic Ductal Adenocarcinoma 51 1.797
63
P INS002 in Situ Carcinoma 53 1.797
64
NNL005 Non-Alcoholic Fatty Liver Disease 63 1.675
65
c HRD173 Hereditary Late-Onset Parkinson Disease 49 1.650
66
TRD006 Tardive Dyskinesia 53 1.650
67
ORL015 Oral Squamous Cell Carcinoma 43 1.650
68
CLF001 Cleft Lip 53 1.447
69
HYP066 Hyperglycemia 61 1.447
70
P PLY011 Polycystic Ovary Syndrome 57 1.447
71
HYP060 Hyperinsulinism 54 1.447
72
SML031 Small Cell Carcinoma of the Bladder 46 1.340
73
SPN186 Spinal Cord Injury 61 1.340
74
OST012 Osteoarthritis 77 1.340
75
DWR001 Dwarfism 44 1.340
76
GLM045 Glioma 63 1.296
77
GST103 Gastric Cancer, Hereditary Diffuse 68 1.254
78
LNG039 Lung Squamous Cell Carcinoma 57 1.254
79
P RHM011 Rheumatoid Arthritis 82 1.223
80
MSC007 Muscle Hypertrophy 64 1.223
81
PSY004 Psychotic Disorder 66 1.223
82
P HYP076 Hyperthyroidism 53 1.223
83
GST040 Gastric Adenocarcinoma 67 1.208
84
P TMR010 Tumor Predisposition Syndrome 67 1.161
85
ADN011 Adenoid Cystic Carcinoma 68 1.161
86
ADN089 Adenosquamous Lung Carcinoma 49 1.161
87
BRN015 Bronchiolo-Alveolar Adenocarcinoma 55 1.161
88
SML009 Small Intestine Adenocarcinoma 57 1.111
89
ART140 Arteries, Anomalies of 53 1.094
90
P SPR120 Supranuclear Palsy, Progressive, 1 69 1.094
91
CLF027 Cleft Palate, Isolated 64 1.094
92
c FBR046 Fibrosis of Extraocular Muscles, Congenital, 1 59 1.094
93
P FTT008 Fatty Liver Disease, Nonalcoholic 1 48 1.094
94
LPP008 Lipoprotein Quantitative Trait Locus 65 1.094
95
HMN047 Human Cytomegalovirus Infection 57 1.094
96
MLT157 Multiple System Atrophy 1 69 1.094
97
CLF056 Cleft Lip with or Without Cleft Palate 42 1.094
98
P ART022 Arthritis 71 1.094
99
PLC002 Plica Syndrome 35 1.094
100
SYN007 Synovitis 55 1.094
101
HYP056 Hypoglycemia 65 1.094
102
c PLY162 Polyposis Syndrome, Hereditary Mixed, 1 60 1.005
103
c CLR087 Colorectal Cancer 12 34 1.005
104
CLF004 Cleft Lip/palate 57 0.947
105
AGN016 Aging 54 0.947
106
c AMY091 Amyotrophic Lateral Sclerosis 1 88 0.947
107
TRD008 Triiodothyronine Receptor Auxiliary Protein 33 0.947
108
c MCR130 Microvascular Complications of Diabetes 6 41 0.947
109
KRT019 Keratitis, Hereditary 66 0.947
110
c MCR120 Microvascular Complications of Diabetes 7 47 0.947
111
P MYP004 Myopathy 67 0.947
112
P VNT002 Ventricular Septal Defect 58 0.947
113
P CRN024 Corneal Disease 44 0.947
114
c MCR113 Microvascular Complications of Diabetes 3 52 0.947
115
c MCR133 Microvascular Complications of Diabetes 4 41 0.947
116
P HYP061 Hypertrophic Cardiomyopathy 69 0.947
117
P MLN007 Male Infertility 56 0.947
118
P LTR001 Lateral Sclerosis 58 0.947
119
P INF032 Infertility 57 0.947
120
ORL011 Oral Cancer 60 0.947
121
END041 Endometrial Adenocarcinoma 64 0.821
122
CLN015 Colon Adenocarcinoma 65 0.821
123
ATH013 Atherosclerosis Susceptibility 63 0.773
124
EPD052 Epidermolysis Bullosa Simplex Superficialis 17 0.773
125
CRV035 Cervical Cancer 73 0.773
126
ANX010 Anxiety 70 0.773
127
c PLM164 Pulmonary Hypertension, Primary, 1 76 0.773
128
DLY008 Delayed Sleep Phase Disorder 44 0.773
129
MYL009 Myelodysplastic Syndrome 67 0.773
130
NNL006 Non-Alcoholic Steatohepatitis 54 0.773
131
c LKM061 Leukemia, Acute Myeloid 83 0.773
132
P BDY004 Body Mass Index Quantitative Trait Locus 11 83 0.773
133
DWN001 Down Syndrome 70 0.773
134
OST159 Osteogenic Sarcoma 66 0.773
135
c SML038 Small Cell Cancer of the Lung 69 0.773
136
P MJR007 Major Affective Disorder 1 42 0.773
137
P HNT016 Huntington Disease 73 0.773
138
PLM129 Pulmonary Disease, Chronic Obstructive 74 0.773
139
THY029 Thyroid Carcinoma 51 0.773
140
DGN001 Degenerative Disc Disease 49 0.773
141
P PSR002 Psoriasis 63 0.773
142
P MYL006 Myeloid Leukemia 61 0.773
143
FTT001 Fatty Liver Disease 62 0.773
144
ANV001 Anovulation 47 0.773
145
PST011 Pustulosis of Palm and Sole 52 0.773
146
P VSC007 Vascular Disease 63 0.773
147
SVR004 Severe Combined Immunodeficiency 72 0.773
148
P SLP005 Sleep Disorder 61 0.773
149
P PRP019 Peripheral Nervous System Disease 58 0.773
150
LPD008 Lipid Metabolism Disorder 62 0.773
151
HYP266 Hypoxia 57 0.773
152
c GLM047 Glioma Susceptibility 3 33 0.749
153
c MSM022 Mismatch Repair Cancer Syndrome 1 70 0.749
154
c GLM025 Glioma Susceptibility 2 30 0.749
155
c GLM043 Glioma Susceptibility 9 30 0.749
156
P GLM040 Glioma Susceptibility 1 71 0.749
157
MNN043 Meningioma, Familial 79 0.749
158
P OLG002 Oligodendroglioma 66 0.749
159
P PTT006 Pituitary Adenoma 55 0.703
160
c PRS097 Prostate Cancer, Hereditary, 1 39 0.580
161
c PRS070 Prostate Cancer, Hereditary, 12 22 0.580
162
c PRS071 Prostate Cancer, Hereditary, 13 25 0.580
163
c PRS117 Prostate Cancer, Hereditary, 11 24 0.580
164
ESP021 Esophageal Cancer 83 0.580
165
c PRS114 Prostate Cancer, Hereditary, 2 33 0.580
166
BRS099 Breast Ductal Carcinoma 61 0.580
167
PRS015 Prostate Signet Ring Cell Adenocarcinoma 25 0.580
168
c WLF013 Wolfram Syndrome 1 60 0.547
169
SDD008 Sudden Sensorineural Hearing Loss 41 0.547
170
TCH005 Tièche-Jadassohn Nevus 28 0.547
171
PRC049 Precursor T-Cell Acute Lymphoblastic Leukemia 45 0.547
172
RST023 Resting Heart Rate, Variation in 40 0.547
173
c BDY010 Body Mass Index Quantitative Trait Locus 4 46 0.547
174
RTC012 Reticuloendotheliosis, X-Linked 35 0.547
175
YMN001 Yemenite Deaf-Blind Hypopigmentation Syndrome 66 0.547
176
INS024 Insulin-Like Growth Factor I 78 0.547
177
c BDY011 Body Mass Index Quantitative Trait Locus 10 45 0.547
178
c BDY005 Body Mass Index Quantitative Trait Locus 9 47 0.547
179
PLY150 Polykaryocytosis Inducer 29 0.547
180
BRK010 Burkitt Lymphoma 66 0.547
181
c BDY012 Body Mass Index Quantitative Trait Locus 7 44 0.547
182
MLR004 Malaria 80 0.547
183
c MCR115 Microvascular Complications of Diabetes 5 65 0.547
184
P INF037 Inflammatory Bowel Disease 53 0.547
185
c FNC028 Fanconi Anemia, Complementation Group L 46 0.547
186
c ATS007 Autism Spectrum Disorder 72 0.547
187
P CRB045 Cerebellar Hypoplasia 40 0.547
188
BNR002 Bone Resorption Disease 47 0.547
189
P LYM118 Lymphoma 67 0.547
190
CRH005 Crohn's Colitis 53 0.547
191
P CHN012 Chondrosarcoma 57 0.547
192
c FNC042 Fanconi Anemia, Complementation Group D2 54 0.547
193
c BDY006 Body Mass Index Quantitative Trait Locus 8 44 0.547
194
P LKM062 Leukemia, Acute Lymphoblastic 69 0.547
195
c ART101 Aortic Valve Disease 2 66 0.547
196
c BDY017 Body Mass Index Quantitative Trait Locus 14 45 0.547
197
c PCH010 Pachyonychia Congenita 3 43 0.547
198
c BDY020 Body Mass Index Quantitative Trait Locus 19 52 0.547
199
c HLP022 Holoprosencephaly 8 22 0.547
200
c BDY015 Body Mass Index Quantitative Trait Locus 12 46 0.547
201
P ART106 Arterial Calcification, Generalized, of Infancy, 1 48 0.547
202
MYL069 Myeloma, Multiple 77 0.547
203
c THY109 Thyroid Cancer, Nonmedullary, 1 55 0.547
204
P SPP010 Suppressor of Tumorigenicity 3 51 0.547
205
c NMN015 Niemann-Pick Disease, Type C1 68 0.547
206
RNL114 Renal Cell Carcinoma, Nonpapillary 80 0.547
207
THY111 Thyroid Carcinoma, Familial Medullary 67 0.547
208
CHL065 Cholangiocarcinoma 58 0.547
209
c NMN014 Niemann-Pick Disease, Type C2 49 0.547
210
P PRK039 Parkinsonism 55 0.547
211
CRH001 Crohn's Disease 80 0.547
212
P HLP001 Holoprosencephaly 69 0.547
213
SCH012 Schizoaffective Disorder 50 0.547
214
P RHB003 Rhabdomyosarcoma 66 0.547
215
ULC004 Ulcerative Colitis 74 0.547
216
GLL048 Glial Tumor 52 0.547
217
P ALP009 Alopecia Areata 59 0.547
218
P ALP008 Alopecia 54 0.547
219
47X002 47,xyy 48 0.547
220
NRN001 Neuroendocrine Carcinoma 47 0.547
221
THY125 Thyroid Gland Medullary Carcinoma 48 0.547
222
MLG079 Malignant Pleural Mesothelioma 42 0.547
223
c BDY019 Body Mass Index Quantitative Trait Locus 18 47 0.547
224
ATX031 Ataxia, Combined Cerebellar and Peripheral, with Hearing Loss and Diabetes Mellitus 58 0.547
225
HLX001 Helix Syndrome 48 0.547
226
c DRR018 Diarrhea 9 25 0.547
227
CMB007 Combined Immunodeficiency 57 0.547
228
P SNS001 Sensorineural Hearing Loss 59 0.547
229
CRB004 Cerebral Artery Occlusion 45 0.547
230
OSM001 Osmotic Diarrhea 28 0.547
231
c DLT002 Dilated Cardiomyopathy 78 0.547
232
CHG001 Chagas Disease 66 0.547
233
P LKM002 Leukemia 67 0.547
234
P NMN002 Niemann-Pick Disease 60 0.547
235
INT079 Intrahepatic Cholangiocarcinoma 51 0.547
236
TCL027 T-Cell Acute Lymphoblastic Leukemia 51 0.547
237
P KDN017 Kidney Cancer 61 0.547
238
P BNG032 Benign Mesothelioma 53 0.547
239
P SCL048 Sclerosteosis 58 0.547
240
P OST001 Osteopetrosis 71 0.547
241
PLS007 Plasmodium Falciparum Malaria 52 0.547
242
P DRR001 Diarrhea 55 0.547
243
STT001 Status Epilepticus 59 0.547
244
P SCK005 Sickle Cell Disease 56 0.547
245
CHR178 Chromosomal Triplication 34 0.547
246
c ERL029 Early-Onset, Autosomal Dominant Alzheimer Disease 59 0.547
247
CKT002 Cakut 47 0.504
248
THY124 Thyroid Gland Papillary Carcinoma 39 0.474
249
LNG012 Lung Occult Squamous Cell Carcinoma 20 0.474
250
LNG007 Lung Mixed Small Cell and Squamous Cell Carcinoma 21 0.474
251
P BLD134 Bladder Cancer 79 0.335
252
IRN008 Iron Overload in Africa 51 0.335
253
P RTH006 Rothmund-Thomson Syndrome, Type 2 67 0.335
254
c CHL136 Cholestasis, Progressive Familial Intrahepatic, 2 57 0.335
255
RMB001 Rombo Syndrome 30 0.335
256
LNG111 Lung Non-Squamous Non-Small Cell Carcinoma 56 0.335
257
HPT079 Hepatoid Adenocarcinoma 39 0.335
258
P TRC095 Trichoepithelioma, Multiple Familial, 1 32 0.335
259
c BSL024 Basal Cell Carcinoma 1 55 0.335
260
BSL044 Basal Cell Carcinoma, Infundibulocystic 35 0.335
261
RJS001 Ruijs-Aalfs Syndrome 47 0.335
262
c BSL034 Basal Cell Carcinoma 7 26 0.335
263
c HPT073 Hepatitis C Virus 71 0.335
264
PLM173 Palmoplantar Hyperkeratosis with Squamous Cell Carcinoma of Skin and 46,xx Sex Reversal 34 0.335
265
PDT042 Pediatric Hepatocellular Carcinoma 49 0.335
266
P BLD062 Bile Duct Cancer 67 0.335
267
CYS004 Cystic Basal Cell Carcinoma 36 0.335
268
SRC003 Sarcomatoid Basal Cell Carcinoma 28 0.335
269
P LNG021 Lung Occult Small Cell Carcinoma 20 0.335
270
NDL009 Nodular Basal Cell Carcinoma 40 0.335
271
MTT001 Metatypical Basal Cell Carcinoma 32 0.335
272
PGM002 Pigmented Basal Cell Carcinoma 31 0.335
273
MCR016 Micronodular Basal Cell Carcinoma 34 0.335
274
INF027 Infiltrative Basal Cell Carcinoma 32 0.335
275
LNG019 Lung Combined Type Small Cell Carcinoma 32 0.335
276
SKN022 Skin Squamous Cell Carcinoma 54 0.335
277
ANL013 Anal Margin Basal Cell Carcinoma 18 0.335
278
SBC013 Sebaceous Basal Cell Carcinoma 13 0.335
279
ADM002 Adamantinoid Basal Cell Epithelioma 20 0.335
280
CLR015 Clear Cell Basal Cell Carcinoma 39 0.335
281
ADN015 Adenoid Basal Cell Carcinoma 31 0.335
282
SGN001 Signet Ring Basal Cell Carcinoma 32 0.335
283
c BSL007 Basal Cell Carcinoma 68 0.335
284
c PRG047 Progressive Familial Intrahepatic Cholestasis 64 0.335
285
ADL096 Adult Hepatocellular Carcinoma 60 0.335
286
FBR086 Fibrolamellar Carcinoma 59 0.335
287
HPT011 Hepatocellular Clear Cell Carcinoma 46 0.335
288
END032 Endometrial Clear Cell Adenocarcinoma 34 0.335
289
PNS010 Penis Squamous Cell Carcinoma 45 0.335
290
PNS005 Penis Mixed Squamous Cell Carcinoma 12 0.335
291
PSD011 Pseudovascular Skin Squamous Cell Carcinoma 16 0.335
292
9Q2001 9q22.3 Microdeletion 24 0.335
293
INF057 Inflammatory Linear Verrucous Epidermal Nevus 33 0.335
294
LNR004 Linear Porokeratosis 33 0.335
295
PTY007 Pityriasis Rotunda 26 0.335
Content
Loading form....